阿斯匹林与二陈汤或清上蠲痛汤在健康成人的药代与药效相互作用
本研究在14名健康成人中开展开放、随机、三周期、两序列交叉试验,评估阿斯匹林单用或与IJT(二陈汤)或CGT(清上蠲痛汤)联用的药代与药效相互作用。结果显示两方剂均增强阿斯匹林抗血小板效应(TXB2最大变化显著降低),但药代趋势不一,短期安全,长期联用需临床关注。
要点
- IJT与CGT均可显著增强阿斯匹林抗血小板效应,表现为TXB2最大变化降低。
- IJT联用呈增加ASA暴露、降低SA暴露的非显著趋势;CGT呈降低ASA暴露趋势。
- 短期联用安全耐受,但增强的抗血小板效应提示长期合用需警惕相互作用。
核心结论
- IJT和CGT与阿斯匹林联用倾向于改变阿斯匹林的药代特征并增强其抗血小板活性,短期安全但长期使用需临床关注潜在相互作用。
研究设计与样本
- 开放、随机、三周期、两序列交叉试验,纳入14名健康成人,比较阿斯匹林单用与联用IJT或CGT。
主要发现
- 与IJT联用时ASA的AUClast几何最小二乘均值比(90%CI)为1.4362(0.7547-2.7335),呈增加趋势但不显著,SA暴露降低。
- 与CGT联用时ASA的AUClast几何最小二乘均值比为0.7695(0.4092-1.4472),呈降低趋势。
- 两方剂联用均较单用阿斯匹林显著降低TXB2相对基线的最大变化(MCFB),提示抗血小板效应增强。
- 联用安全且耐受良好。
关键数值与推荐
- 药代参数:ASA与SA的AUClast几何最小二乘均值比及90%CI。
- 药效指标:血清TXB2相对基线最大变化(MCFB)。
- 阿斯匹林单次剂量100 mg,IJT与CGT为多剂量给药。
临床怎么用
- 对卒中后常联用阿斯匹林与IJT或CGT的患者,应关注抗血小板效应增强的可能,尤其长期联用时加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Ijintang (IJT) and Cheongsanggyeontongtang (CGT) are traditional herbal medicines frequently administered to post-stroke patients in the Republic of Korea, a population that commonly co-administer them with aspirin for secondary stroke prevention. This concurrent use creates a high potential for clinically significant herb-drug interactions. AIM OF THE STUDY: This study aimed to evaluate the potential pharmacokinetic (PK) and pharmacodynamic (PD) interactions between aspirin and two herbal formulas, IJT and CGT, in healthy adults. MATERIALS AND METHODS: An open-label, randomized, three-period, two-sequence crossover trial was conducted in 14 healthy volunteers. Participants received a single 100 mg dose of aspirin alone, and then with multiple doses of IJT or CGT. PK parameters of acetylsalicylic acid (ASA) and salicylic acid (SA), and PD effects on serum thromboxane B2 (TXB2) were assessed. RESULTS: Co-administration with IJT showed a non-significant trend towards increased ASA exposure (Geometric LSM ratio [90 % CI] for AUClast: 1.4362 [0.7547-2.7335]) and decreased SA exposure. Conversely, CGT co-administration showed a trend toward decreased ASA exposure (Geometric LSM ratio for AUClast: 0.7695 [0.4092-1.4472]). Both herbal medicines enhanced aspirin's antiplatelet effect, evidenced by a significant reduction in the maximum change from baseline (MCFB) of TXB2 compared to aspirin alone. The co-administration was safe and well-tolerated. CONCLUSIONS: Co-administration of IJT and CGT with aspirin tended to alter the PK profile of aspirin and enhance its antiplatelet activity. While appearing safe in the short-term, the augmented antiplatelet effect warrants clinical awareness of potential interactions, especially with long-term use.
引用
- Hwang I, Kim JH, Song J, et al. Pharmacokinetic and pharmacodynamic herb-drug interaction of aspirin with Ijintang (Er Chen Tang) or Cheongsanggyeontongtang (Qing Shang Juan Tong Tang): An exploratory study in healthy adults. J Ethnopharmacol. 2025. PMID: 41135614. doi:10.1016/j.jep.2025.120776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。